Long-Term Care Industry Touts Business Case for Antipsychotic Reduction

The American Health Care Association and National Center for Assisted Living have posted a fact sheet making the business case in favor of reducing the use of antipsychotic drugs on residents of long-term care facilities. Essentially, the fact sheet states that facilities and taxpayers can save money by reducing antipsychotic use and using person-centered approaches to resident care. The staff are happier, the residents and their families are more satisfied, and facilities can gain a competitive advantage in attracting residents. As we have been saying all along: the least medicating approach to dementia care is a win-win-win.

Share

About achicotel

Anthony Chicotel is a staff attorney for CANHR. His areas of expertise include the rights of long-term care residents, nursing home litigation, health care decision-making, and conservatorships.
Print this page.
Share

Responses to CANHR blog postings do not reflect the opinions of CANHR or its staff members.

Leave a Reply